Bioavailability of dexmedetomidine after intranasal administration
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The aim of this proof-of-concept study was to characterize the pharmacokinetics and pharmacodynamics of intranasal dexmedetomidine compared with its intravenous administration in a small number of healthy volunteers.
Single doses of 84 μg of dexmedetomidine were given once intravenously and once intranasally to seven healthy men. Plasma dexmedetomidine concentrations were measured for 10 h, and pharmacokinetic variables were calculated with standard noncompartmental methods. Heart rate, blood pressure, concentrations of adrenaline and noradrenaline in plasma, and central nervous system drug effects (with the Maddox wing, Bispectral Index, and three visual analog scales) were monitored to assess the pharmacological effects of dexmedetomidine.
Six individuals were included in the analyses. Following intranasal administration, peak plasma concentrations of dexmedetomidine were reached in 38 (15–60) min and its absolute bioavailability was 65% (35–93%) (medians and ranges). Pharmacological effects were similar with both routes of administration, but their onset was more rapid after intravenous administration.
Dexmedetomidine is rather rapidly and efficiently absorbed after intranasal administration. Compared with intravenous administration, intranasal administration may be a feasible alternative in patients requiring light sedation.
- Hayashi, Y, Maze, M (1993) Alpha 2 adrenoceptor agonists and anaesthesia. Br J Anaesth 71: pp. 108-118 CrossRef
- Yuen, VM, Irwin, MG, Hui, TW, Yuen, MK, Lee, LH (2007) A double-blind, crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth Analg 105: pp. 374-380 CrossRef
- Yuen, VM, Hui, TW, Irwin, MG, Yuen, MK (2008) A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth Analg 106: pp. 1715-1721 CrossRef
- Yuen, VM, Hui, TW, Irwin, MG, Yao, TJ, Wong, GL, Yuen, MK (2010) Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia 65: pp. 922-929 CrossRef
- Guidance for Industry Bioanalytical Method Validation U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM) May 2001 BP http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf
- Ji, QC, Zhou, JY, Gonzales, RJ, Gage, EM, El-Shourbagy, TA (2004) Simultaneous quantitation of dexmedetomidine and glucuronide metabolites (G-Dex-1 and G-Dex-2) in human plasma utilizing liquid chromatography with tandem mass spectrometric detection. Rapid Commun Mass Spectrom 18: pp. 1753-1760 CrossRef
- Scheinin, M, Karhuvaara, S, Ojala-Karlsson, P, Kallio, A, Koulu, M (1991) Plasma 3, 4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Life Sci 49: pp. 75-84 CrossRef
- Hannington-Kiff, JG (1970) Measurement of recovery from outpatient general anaesthesia with a simple ocular test. Br Med J 3: pp. 132-135 CrossRef
- Sigl, JC, Chamoun, NG (1994) An introduction to bispectral analysis for the electroencephalogram. J Clin Monit 10: pp. 392-404 CrossRef
- Bond, A, Lader, MH (1974) The use of visual analogue scales in rating subjective feelings. Br J Med Psychol 1974: pp. 211-218
- Anttila, M, Penttila, J, Helminen, A, Vuorilehto, L, Scheinin, H (2003) Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 56: pp. 691-693 CrossRef
- Takala, A, Kaasalainen, V, Seppala, T, Kalso, E, Olkkola, KT (1997) Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone. Acta Anaesthesiol Scand 41: pp. 309-312 CrossRef
- Bioavailability of dexmedetomidine after intranasal administration
European Journal of Clinical Pharmacology
Volume 67, Issue 8 , pp 825-831
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, University of Turku and Turku University Hospital, P.O. Box 52, FI-20521, Turku, Finland
- 2. Department of Pharmacology, Drug Development and Therapeutics, University of Turku and Unit of Clinical Pharmacology, TYKSLAB, Turku, Finland